QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 pharma-two-b-and-hepion-pharmaceuticals-files-registration-statement-on-form-f-4-related-to-proposed-merger-proposed-transaction-expected-to-close-in-q4

The Registration Statement contains a proxy statement/prospectus in connection with the proposed merger transaction pursuant to...

 fatty-liver-focused-hepion-pharmaceuticals-agrees-to-merge-with-israel-based-parkinsons-disease-drug-developer

Hepion Pharmaceuticals announces merger with Pharma Two B Ltd., creating a combined company focused on Parkinson's disease ...

Core News & Articles
Market-Moving News for July 22nd
07/22/2024 12:21:08

RR: 100% | Richtech Robotics Celebrates Completion of Installation of ADAM at Ghost Kitchens inside Dawsonville, GA Walmart MIR...

 why-is-liver-disease-drug-developer-hepion-pharmaceuticals-stock-trading-lower-on-monday

Updates on Hepion Pharmaceuticals' ASCEND-NASH Trial, now in wind-down phase. Explore insights into Phase 2b study progress...

 hepion-pharmaceuticals-says-given-the-number-of-enrolled-nash-patients-to-date-and-the-low-probability-of-generating-relevant-efficacy-data-to-support-a-registrational-trial-with-our-current-cash-resources-we-have-opted-to-wind-down-the-program-and-assure-that-patients-are-transitioned-out-of-the-trial-in-a-safe-and-compliant-manner

"We are disappointed to announce the wind-down of our Phase 2 NASH trial, which we attribute entirely to resource constrain...

 hepion-pharmaceuticals-initiates-wind-down-activities-in-phase-2b-ascend-nash-trial

Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION